Joseph P. Lucia & Associates, LLC Bristol Myers Squibb CO Transaction History

Joseph P. Lucia & Associates, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $72,692 - $80,059	1,001 Added 188.87%	1,531 $118,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $32,584 - $39,071	530 New	530 $39,000
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $16,142 - $18,818	-301 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $59 - $69	1 Added 0.33%	301 $18,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $61 - $67	1 Added 0.33%	300 $20,000
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.34%	299 $19,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $17,206 - $19,498	298 New	298 $19,000
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $17,573 - $19,473	-306 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $54 - $64	1 Added 0.33%	306 $18,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $788 - $1,146	-17 Reduced 5.28%	305 $17,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $5,905 - $7,702	120 Added 59.41%	322 $21,000
Q2 2019 Jul 23, 2019	SELL	$44.62 - $49.34 $391,808 - $433,254	-8,781 Reduced 97.75%	202 $9,000
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $405,312 - $483,285	8,983 New	8,983 $192,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.